Lee's Pharmaceutical Holdings Limited (0950.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 895.23M |
| Enterprise Value | 855.6M |
| P/E Ratio | 7.05 |
| PEG Ratio | 0.07 |
| Price/Sales Ratio | 0.45 |
| Price/Book Ratio | 0.32 |
| Enterprise/Revenue | 0.42 |
| Enterprise/EBITDA | 3.07 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.06 |
| Operating Margin | 0.06 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.05 |
Income Statement
| Revenue | 1.44B |
| Revenue/Share | 2.44 |
| Gross Profit | 729.56M |
| EBITDA | 198.04M |
| Net Income | 91.94M |
| Diluted EPS | 0.16 |
Balance Sheet
| Total Cash | 349.9M |
| Total Cash/Share | 0.59 |
| Total Debt | 310.27M |
| Total Debt/Equity | 0.15 |
| Current Ratio | 1.03 |
| Book Value Per Share | 3.23 |
Price History
| 52-Week Change | -23.08 |
| 52-Week High | 2.7 |
| 52-Week Low | 0.99 |
| Moving Average 50 Days | 1.13 |
| Moving Average 200 Days | 1.56 |
Statistics
| Average Volume | 788,915 |
| Shares Outstanding | 588.84M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.05 |
| Trailing Annual Dividend Yield | 4.09 |
| Payout Ratio | 0.37 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
